Literature DB >> 20054615

Early predictors of cardiac decompensation in experimental volume overload.

Christelle Oliver-Dussault1, Alexis Ascah, Mariannick Marcil, Jimmy Matas, Sylvie Picard, Philippe Pibarot, Yan Burelle, Christian F Deschepper.   

Abstract

In humans, volume overload (VOL) increases the risk of sudden cardiac death, but there is also important inter-individual variability, presumably because of differences in genetic backgrounds. Although VOL has rapid effects on myocardial properties, it is not known to which extent the severity of these early responses correlate with the effect of sustained VOL on mortality. In order to test this question, we induced VOL in male rats from two genetically distinct strains [i.e., Sprague-Dawley (SD) and Wistar Kyoto-derived Hyperactive (WKHA) rats] by creating a surgical aorto-caval fistula (ACF). Only 36% of SD rats remained alive after 39 weeks of ACF, in contrast to 82% of the operated WKHA rats. We also monitored myocardial hemodynamic function, mitochondrial properties, left ventricular (LV) morphology and LV wall diastolic properties at different times ranging from 2 to 12 weeks after either ACF or sham surgery. ACF had a rapid impact on the LV walls of both rat strains, but the only variables that were affected to a greater extent in the mortality-prone SD strain were normalized LV weight, LV cavity area, and myocardial wall stiffness. In contrast, there were only marginal strain-related differences in the way ACF affected hemodynamic and mitochondrial functions. Thus, while early morphologic responses of LV walls to ACF (along with their downstream consequences on myocardial diastolic wall stress) correlated well with strain-dependent differences in late mortality, other functional changes showed no predictive effects. Close monitoring of early changes in cardiac geometry (as well as new methods to analyze myocardial diastolic strain) might, therefore, be helpful to further improve risk stratification in humans with volume overload cardiopathies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20054615     DOI: 10.1007/s11010-009-0361-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  47 in total

1.  Microplate assay for the measurement of hydroxyproline in acid-hydrolyzed tissue samples.

Authors:  S Brown; M Worsfold; C Sharp
Journal:  Biotechniques       Date:  2001-01       Impact factor: 1.993

2.  Regulation of fibrillar collagen gene expression and protein accumulation in volume-overloaded cardiac hypertrophy.

Authors:  T Namba; H Tsutsui; H Tagawa; M Takahashi; K Saito; T Kozai; M Usui; K Imanaka-Yoshida; T Imaizumi; A Takeshita
Journal:  Circulation       Date:  1997-05-20       Impact factor: 29.690

3.  Cardiac mast cell-mediated activation of gelatinase and alteration of ventricular diastolic function.

Authors:  Amanda L Chancey; Gregory L Brower; Joseph S Janicki
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-06       Impact factor: 4.733

4.  Sudden death in mitral regurgitation due to flail leaflet.

Authors:  F Grigioni; M Enriquez-Sarano; L H Ling; K R Bailey; J B Seward; A J Tajik; R L Frye
Journal:  J Am Coll Cardiol       Date:  1999-12       Impact factor: 24.094

5.  Myocardial dysfunction with increased ventricular compliance in volume overload hypertrophy.

Authors:  Laercio Martins De Stefano; Luiz Shiguero Matsubara; Beatriz Bojikian Matsubara
Journal:  Eur J Heart Fail       Date:  2006-03-06       Impact factor: 15.534

6.  Multiple trait measurements in 43 inbred mouse strains capture the phenotypic diversity characteristic of human populations.

Authors:  Karen L Svenson; Randy Von Smith; Phyllis A Magnani; Heather R Suetin; Beverly Paigen; Jürgen K Naggert; Renhua Li; Gary A Churchill; Luanne L Peters
Journal:  J Appl Physiol (1985)       Date:  2007-02-22

7.  Temporal evaluation of left ventricular remodeling and function in rats with chronic volume overload.

Authors:  G L Brower; J R Henegar; J S Janicki
Journal:  Am J Physiol       Date:  1996-11

8.  Characterization of cardiac hypertrophy and heart failure due to volume overload in the rat.

Authors:  Xi Wang; Bin Ren; Songyan Liu; Emmanuelle Sentex; Paramjit S Tappia; Naranjan S Dhalla
Journal:  J Appl Physiol (1985)       Date:  2003-02

Review 9.  Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms.

Authors:  K T Weber; Y Sun; S C Tyagi; J P Cleutjens
Journal:  J Mol Cell Cardiol       Date:  1994-03       Impact factor: 5.000

10.  Risk, determinants, and outcome implications of progression of mitral regurgitation after diagnosis of mitral valve prolapse in a single community.

Authors:  Jean-Francois Avierinos; Delphine Detaint; David Messika-Zeitoun; Dania Mohty; Maurice Enriquez-Sarano
Journal:  Am J Cardiol       Date:  2008-01-16       Impact factor: 2.778

View more
  8 in total

1.  Inhibition of soluble epoxide hydrolase does not improve the course of congestive heart failure and the development of renal dysfunction in rats with volume overload induced by aorto-caval fistula.

Authors:  L Červenka; V Melenovský; Z Husková; A Sporková; M Bürgelová; P Škaroupková; S H Hwang; B D Hammock; J D Imig; J Sadowski
Journal:  Physiol Res       Date:  2015-06-05       Impact factor: 1.881

2.  Effect of angiotensin-converting enzyme blockade, alone or combined with blockade of soluble epoxide hydrolase, on the course of congestive heart failure and occurrence of renal dysfunction in Ren-2 transgenic hypertensive rats with aorto-caval fistula.

Authors:  P Kala; L Sedláková; P Škaroupková; L Kopkan; Z Vaňourková; M Táborský; A Nishiyama; S H Hwang; B D Hammock; J Sadowski; V Melenovský; J D Imig; L Červenka
Journal:  Physiol Res       Date:  2018-03-12       Impact factor: 1.881

3.  Bone marrow-derived multipotent stromal cells promote myocardial fibrosis and reverse remodeling of the left ventricle.

Authors:  Timur Fatkhudinov; Galina Bolshakova; Irina Arutyunyan; Andrey Elchaninov; Andrey Makarov; Evgeniya Kananykhina; Oksana Khokhlova; Arkady Murashev; Valeria Glinkina; Dmitry Goldshtein; Gennady Sukhikh
Journal:  Stem Cells Int       Date:  2015-01-21       Impact factor: 5.443

4.  Computational analysis of the hemodynamic characteristics under interaction influence of β-blocker and LVAD.

Authors:  Kaiyun Gu; Zhe Zhang; Yu Chang; Bin Gao; Feng Wan
Journal:  Biomed Eng Online       Date:  2018-12-03       Impact factor: 2.819

5.  Pharmacological Blockade of Soluble Epoxide Hydrolase Attenuates the Progression of Congestive Heart Failure Combined With Chronic Kidney Disease: Insights From Studies With Fawn-Hooded Hypertensive Rats.

Authors:  Šárka Vacková; Libor Kopkan; Soňa Kikerlová; Zuzana Husková; Janusz Sadowski; Elzbieta Kompanowska-Jezierska; Bruce D Hammock; John D Imig; Miloš Táborský; Vojtěch Melenovský; Luděk Červenka
Journal:  Front Pharmacol       Date:  2019-01-23       Impact factor: 5.810

6.  Functional and pathological characteristics of reversible remodeling in a canine right ventricle in response to volume overloading and volume unloading.

Authors:  Kazuhiko Ishimaru; Shigeru Miyagawa; Satsuki Fukushima; Haruki Ide; Takaya Hoashi; Toshiharu Shibuya; Takayoshi Ueno; Yoshiki Sawa
Journal:  Surg Today       Date:  2014-02-13       Impact factor: 2.549

7.  Isovolumic loading of the failing heart by intraventricular placement of a spring expander attenuates cardiac atrophy after heterotopic heart transplantation.

Authors:  Martin Pokorný; Iveta Mrázová; Jan Šochman; Vojtěch Melenovský; Jiří Malý; Jan Pirk; Lenka Červenková; Janusz Sadowski; Zdeněk Čermák; Karel Volenec; Šárka Vacková; Hana Maxová; Luděk Červenka; Ivan Netuka
Journal:  Biosci Rep       Date:  2018-06-27       Impact factor: 3.840

8.  Effects of Renal Denervation on the Enhanced Renal Vascular Responsiveness to Angiotensin II in High-Output Heart Failure: Angiotensin II Receptor Binding Assessment and Functional Studies in Ren-2 Transgenic Hypertensive Rats.

Authors:  Zuzana Honetschlägerová; Lucie Hejnová; Jiří Novotný; Aleš Marek; Luděk Červenka
Journal:  Biomedicines       Date:  2021-11-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.